The medical isotopes market is really a global one. When we look at the future, and we've done a third party analysis of what is the projected demand and supply, which comes out of the OECD's Nuclear Energy Agency, the expectation is that supply will meet the demand even after the NRU ceases to produce medical isotopes going forward.
What happens after 2016? Really, the market dynamics will play out and we suspect that the projects that we've been funding through NRCan, cyclotrons and linear accelerators, will have a share of the market. At this point in time we don't know exactly which source of medical isotopes will actually be supplying the Canadian market, but it will be a global market. When we look at the analysis we're confident that supply is projected to meet demand.